Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.

Abstract

Malignant carcinoid tumours, islet cell tumours and medullary carcinomas of the thyroid are tumours with similar clinical features. In patients with unresectable or metastatic tumours leukocyte interferon (IFN) and recombinant human (rh) IFN have demonstrated efficacy. Twenty-four evaluable patients with progressive tumours were treated with 2.5 megaunits… (More)
DOI: 10.1038/bjc.1992.372

Topics

4 Figures and Tables

Cite this paper

@article{Biesma1992RecombinantIA, title={Recombinant interferon alpha-2b in patients with metastatic apudomas: effect on tumours and tumour markers.}, author={Bonne Biesma and Pax H. B. Willemse and N. H. Mulder and Robin Verschueren and Ido P. Kema and Henk W A de Bruijn and Piet E. Postmus and Dirk Th. Sleijfer and Elisabeth G. E. de Vries}, journal={British Journal of Cancer}, year={1992}, volume={66}, pages={850 - 855} }